Fig. 1From: Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective studyA Maintenance treatment options after 4–6 cycles of induction therapy in 215 patients. B Reasons for maintenance treatment discontinuationBack to article page